In the aftermath of the pandemic, vaccine technology is rapidly evolving. Scientists are developing advanced vaccine strategies to mitigate the risk of pathogen infection and protect against diseases such as cancer. In this seminar, Magnus Hoffmann, Anna Blakney, Aliasger Salem, and Jinjun Shi will discuss the latest developments in vaccine technology.
Topics to be covered
- Genetically encoded nanoparticles for hybrid mRNA vaccines against SARS-CoV-2
- Self-amplifying RNA and nanoparticle design for more efficient vaccines
- Biodegradable particles for cancer vaccine delivery
- mRNA nanomedicine for cancer vaccines and immunotherapies
Monday, February 27th, 2023 | 1:30 PM - 4:30 PM Eastern Time
This seminar will be available to view live and on demand.
Speakers
Magnus Hoffmann, PhD
Independent Research Fellow
California Institute of Technology
Anna Blakney, PhD
Assistant Professor
University of British Columbia
Aliasger Salem, PhD
Bighley Endowed Chair and Professor
University of Iowa
Jinjun Shi, PhD
Associate Professor
Harvard Medical School